• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tuberculosis diagnostics: Challenges and opportunities.结核病诊断:挑战与机遇。
Lung India. 2012 Jul;29(3):259-66. doi: 10.4103/0970-2113.99112.
2
Tuberculosis结核病
3
Tuberculosis: a new vision for the 21st century.结核病:21世纪的新视角。
Kekkaku. 2009 Nov;84(11):721-6.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
6
The re-emergence of tuberculosis.结核病的再度出现。
Annu Rev Public Health. 1994;15:303-23. doi: 10.1146/annurev.pu.15.050194.001511.
7
Improving diagnosis and case management of patients with tuberculosis: A review of gaps, needs and potential solutions in accessing laboratory diagnostics.改善结核病患者的诊断和病例管理:获取实验室诊断服务方面的差距、需求和潜在解决方案综述。
Infect Genet Evol. 2019 Aug;72:131-140. doi: 10.1016/j.meegid.2018.08.030. Epub 2018 Oct 13.
8
Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.欧盟的耐药结核病:控制的机遇与挑战。
Tuberculosis (Edinb). 2010 May;90(3):182-7. doi: 10.1016/j.tube.2010.03.008. Epub 2010 Apr 10.
9
Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.抗击广泛耐药结核病计划:联邦结核病特别工作组的建议
MMWR Recomm Rep. 2009 Feb 13;58(RR-3):1-43.
10
[Recent progress in mycobacteriology].[分枝杆菌学的最新进展]
Kekkaku. 2007 Oct;82(10):783-99.

引用本文的文献

1
Evaluation of the PATHFAST TB LAM Ag assay as a treatment monitoring tool for pulmonary tuberculosis in Nairobi, Kenya.评估PATHFAST结核脂阿拉伯甘露聚糖抗原检测法作为肯尼亚内罗毕肺结核治疗监测工具的效果。
Trop Med Health. 2025 Jul 1;53(1):89. doi: 10.1186/s41182-025-00771-z.
2
Clinical diagnosis of TB: lessons on misdiagnosis and overdiagnosis.结核病的临床诊断:关于误诊和过度诊断的教训
Public Health Action. 2025 Jun 4;15(2):93-95. doi: 10.5588/pha.25.0012. eCollection 2025 Jun.
3
Applicability of TB-LAMP test for diagnosis of pulmonary TB among HIV-positive individuals.结核环介导等温扩增试验在HIV阳性个体中诊断肺结核的适用性。
IJTLD Open. 2025 Jan 1;2(1):26-32. doi: 10.5588/ijtldopen.24.0410. eCollection 2025 Jan.
4
Early detection of tuberculosis: a systematic review.结核病的早期检测:一项系统综述
Pneumonia (Nathan). 2024 Jul 5;16(1):11. doi: 10.1186/s41479-024-00133-z.
5
Culture-Free Whole Genome Sequencing of Using Ligand-Mediated Bead Enrichment Method.使用配体介导的磁珠富集法进行无培养全基因组测序。
Open Forum Infect Dis. 2024 Jun 15;11(7):ofae320. doi: 10.1093/ofid/ofae320. eCollection 2024 Jul.
6
Epidemiology of multi-drug resistant Tuberculosis in the western region of Kenya.肯尼亚西部地区耐多药结核病的流行病学
AIMS Microbiol. 2024 Apr 22;10(2):273-287. doi: 10.3934/microbiol.2024014. eCollection 2024.
7
Discovery of Antimicrobial Peptides That Can Accelerate Culture Diagnostics of Slow-Growing Mycobacteria Including .能够加速包括……在内的缓慢生长分枝杆菌培养诊断的抗菌肽的发现
Microorganisms. 2023 Sep 2;11(9):2225. doi: 10.3390/microorganisms11092225.
8
Biomarkers That Correlate with Active Pulmonary Tuberculosis Treatment Response: a Systematic Review and Meta-analysis.与活动性肺结核治疗反应相关的生物标志物:系统评价和荟萃分析。
J Clin Microbiol. 2022 Feb 16;60(2):e0185921. doi: 10.1128/JCM.01859-21. Epub 2021 Dec 15.
9
Host and Bacterial Iron Homeostasis, an Underexplored Area in Tuberculosis Biomarker Research.宿主和细菌铁稳态,结核病生物标志物研究中一个尚未充分探索的领域。
Front Immunol. 2021 Oct 29;12:742059. doi: 10.3389/fimmu.2021.742059. eCollection 2021.
10
Identification of a predominant genotype of Mycobacterium tuberculosis in Brazilian indigenous population.鉴定巴西土著人群中结核分枝杆菌的主要基因型。
Sci Rep. 2021 Jan 13;11(1):1224. doi: 10.1038/s41598-020-79621-3.

本文引用的文献

1
Totally drug-resistant tuberculosis in India.印度的完全耐药结核病
Clin Infect Dis. 2012 Feb 15;54(4):579-81. doi: 10.1093/cid/cir889. Epub 2011 Dec 21.
2
Tuberculosis diagnostics: innovating to make an impact.结核病诊断:创新以产生影响。
Expert Rev Anti Infect Ther. 2011 Apr;9(4):381-4. doi: 10.1586/eri.11.18.
3
Immunological biomarkers of tuberculosis.结核的免疫学生物标志物。
Nat Rev Immunol. 2011 May;11(5):343-54. doi: 10.1038/nri2960. Epub 2011 Apr 8.
4
Detection of NASBA amplified bacterial tmRNA molecules on SLICSel designed microarray probes.在 SLICSel 设计的微阵列探针上检测 NASBA 扩增的细菌 tmRNA 分子。
BMC Biotechnol. 2011 Feb 28;11:17. doi: 10.1186/1472-6750-11-17.
5
Evaluation of Cobas TaqMan MTB PCR for detection of Mycobacterium tuberculosis.Cobas TaqMan MTB PCR 检测结核分枝杆菌的评估。
J Clin Microbiol. 2011 Jan;49(1):173-6. doi: 10.1128/JCM.00694-10. Epub 2010 Nov 3.
6
Rapid molecular detection of tuberculosis and rifampin resistance.快速分子检测结核分枝杆菌及利福平耐药性。
N Engl J Med. 2010 Sep 9;363(11):1005-15. doi: 10.1056/NEJMoa0907847. Epub 2010 Sep 1.
7
Efficient differentiation of Mycobacterium avium complex species and subspecies by use of five-target multiplex PCR.利用五重靶标多重 PCR 高效区分鸟分枝杆菌复合群种和亚种。
J Clin Microbiol. 2010 Nov;48(11):4057-62. doi: 10.1128/JCM.00904-10. Epub 2010 Sep 1.
8
Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining.结核分枝杆菌 PPD 诱导的免疫生物标志物可通过多重微珠阵列和细胞内细胞因子染色在英国青少年接种卡介苗后进行体外测量。
BMC Immunol. 2010 Jul 7;11:35. doi: 10.1186/1471-2172-11-35.
9
Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice.结核病的生物标志物和诊断:进展、需求及转化为实践。
Lancet. 2010 May 29;375(9729):1920-37. doi: 10.1016/S0140-6736(10)60359-5. Epub 2010 May 18.
10
Development and evaluation of oligonucleotide chip based on the 16S-23S rRNA gene spacer region for detection of pathogenic microorganisms associated with sepsis.基于 16S-23S rRNA 基因间隔区的寡核苷酸芯片的开发和评估用于检测与脓毒症相关的致病微生物。
J Clin Microbiol. 2010 May;48(5):1578-83. doi: 10.1128/JCM.01130-09. Epub 2010 Mar 17.

结核病诊断:挑战与机遇。

Tuberculosis diagnostics: Challenges and opportunities.

作者信息

Nema Vijay

机构信息

Division of Microbiology and Clinical Pathology, National AIDS Research Institute, Pune, Maharashtra, India.

出版信息

Lung India. 2012 Jul;29(3):259-66. doi: 10.4103/0970-2113.99112.

DOI:10.4103/0970-2113.99112
PMID:22919166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3424866/
Abstract

Tuberculosis (TB) has been a disease affecting almost all parts of the world since ages. Lot many efforts came in the past for improving diagnosis and treatment. Also, an effective vaccine has been sought after for long. With the emergence of resistant strains of Mycobacterium tuberculosis, the causal organisms of tuberculosis, and complexities emerging due to other associated infections and disease conditions, there is a desperate need for further research input in the field. Be it the better medication and care or better resistance management, proper diagnostics holds the key to success. It has been observed that a high burden of the disease was accompanied by resource limitations and poor research set-up. The scenario remained like this for several decades. With the refreshed vision of resourceful countries and funding agencies, funding is being provided in many areas of research in tuberculosis diagnosis and treatment. This review has been written with an aim to bring forth the limitations of available methods in the field of diagnostics and making researchers aware about the changing scenario with better funding opportunities and support. The author visualizes an enthusiasm from all over the world for the development of better modalities and urges scientists to join the struggle at this very perfect time to take the challenge and come forward with innovations in this field.

摘要

自古以来,结核病一直是一种影响着世界几乎所有地区的疾病。过去为改善诊断和治疗付出了诸多努力。此外,长期以来一直在寻求一种有效的疫苗。随着结核分枝杆菌耐药菌株的出现,结核病的致病原,以及由于其他相关感染和疾病状况而出现的复杂性,该领域迫切需要进一步的研究投入。无论是更好的药物治疗和护理,还是更好的耐药管理,正确的诊断都是成功的关键。据观察,该疾病的高负担伴随着资源限制和研究设施简陋。这种情况持续了几十年。随着资源丰富的国家和资助机构的观念更新,结核病诊断和治疗的许多研究领域都获得了资金支持。撰写这篇综述的目的是揭示诊断领域现有方法的局限性,并让研究人员了解随着更好的资金机会和支持而不断变化的情况。作者预见到全世界对开发更好方法的热情,并敦促科学家们在这个绝佳时机加入这场斗争,迎接挑战,在该领域拿出创新成果。